Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


3rd Annual Congress on Infectious Diseases

San Francisco, USA

Eugénie Bergogne-Bérézin

Eugénie Bergogne-Bérézin

Paris University, Bichat Claude-Bernard- Hospital, France

Title: Digestive Tract Diseases and Infections.


Biography: Eugénie Bergogne-Bérézin


          Human digestive tract (DT) is one of the most vulnerable organs to microbial aggressions. A natural bacterial flora in the DT is a source of maturation of immune systems: Lactobacilli, Bifidobacterium lactis contribute to children growth. Normal adult intestinal flora includes Enterobacteriaceae, Escherichia coli, Proteus spp., and anaerobes, as contributors to digestive tract functions. In adults who suffered of recurrent gastric pain, the discovery of Helicobacter pylori, Gram negative micro-aerophilic, helix-shaped organism,  has been shown as responsible for gastric ulcer, Malt lymphoma, adeno-carcinoma: living in acidic areas, (upper digestive tract, 50% of elderly), treatment omeprazole+ clarithromycin has proven efficacy.  Lower intestinal tract can be invaded by species responsible for diarrhea, contagious, of variable severity: Shigella, Salmonella  spp, Vibrio cholerae: in countries with poor hygiene, cholera epidemics often occur. Yersinia enterocolitica, Y.pseudotuberculosis carried by pigs and contaminant to humans, determine sporadic acute gastro-enteritis, (contact with animals, contaminated food).  Intestinal infections should not be treated with antibiotics systematically, as in some cases they result in aggravation, emergence of Clostridium difficile. The presence in intestinal flora of Escherichia coli resistant to β-lactams is a threat for treatment failure. E.coli resistant to β-lactams and carriage of genes of resistance became international problems. In ICU patients, disorganized flora occurs whatever treatment used:  pathogenic MDR are often isolated. To re-establish equilibrium with a “normal “flora”, the development of “Fecal Microbiota  Transplant” becomes extensively used ( in pills or tablets). Another option has been successful using living organisms (“probiotics”) such as fungi (Saccharomyces spp., S.boulardii sp.) can  control ICU diarrhea.